This compound is a pharmaceutical intermediate specifically designed as a precursor for the synthesis of 18F-L-Dopa, a radiolabeled compound used in positron emission tomography (PET) imaging for Parkinson's disease research. It features a protected catechol structure with tert-butyl ester and carbamate groups, along with a boronic ester moiety, which facilitates radiofluorination.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2377146-66-0
Diethyl N-[4-(methylamino)benzoyl]-L-glutamate
pharmaceutical intermediate
Abiraterone N-Oxide
Abiraterone metabolite reference standard
(R)-(-)-2,2-Dimethyl-1,3-dioxolan-4-ylmethyl p-toluenesulfonate
Pharmaceutical intermediate for synthesis
4-Hydroxyindole
Precursor for psilocybin synthesis
tert-butyl (2S)-3-[4,5-bis(methoxymethoxy)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoate
OMEJVTOXRPCWJF-QHCPKHFHSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC(=C(C=C2C[C@@H](C(=O)OC(C)(C)C)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)OCOC)OCOC